Charles W. Newton, Chief Financial Officer at Lyell Immunopharma, Inc. (LYEL), sold 1,453 shares at $10.54 ($15K) on 2025-08-21, disclosed to the SEC on 2025-08-22.
Open-market sale of $15k LYEL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LYEL | SELL | 2025-08-13 | $3K | — | Filing → |
| LYEL | BUY | 2025-03-18 | $224K | — | Filing → |